CYP27B1

Across TCGA pan-cancer cohorts, CYP27B1 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated CYP27B1 data layer compared with 23 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CYP27B1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CYP27B1 expression acts as an unfavorable survival marker.

KIRP, SARC, and SKCM are the cancer types where CYP27B1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Median	All	0.141	0.904	<.001	36	view →
SARC	OS	Median	All	0.151	0.730	.004	9	view →
SKCM	OS	Median	All	0.284	0.788	<.001	9	view →
PRAD	DFS	Median	All	0.617	0.886	.038	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
GBM	DFS	Median	All	0.048	0.242	.006	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

CYP27B1–KIRP (OS)

Open the KIRP breakdown →